Shervanthi Homer-Vanniasinkam, Director at Tissue Regenix, holds 250.00K shares in Tissue Regenix (Ticker: GB:TRX). Most recently, Shervanthi Homer-Vanniasinkam Bought 250,000p shares of Tissue Regenix on Aug 09, 2017 for an estimated value of 25.00K.
What was Shervanthi Homer-Vanniasinkam’s latest transaction?
Shervanthi Homer-Vanniasinkam latest transaction was an Informative Buy of 25.00K.
What was Shervanthi Homer-Vanniasinkam's most profitable transaction?
Shervanthi Homer-Vanniasinkam’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Shervanthi Homer-Vanniasinkam's role in Tissue Regenix?
Shervanthi Homer-Vanniasinkam's role in Tissue Regenix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.